Clinical applications of evoked acoustic emissions: results in normally hearing and hearing-impaired subjects.
Click-evoked otoacoustic emissions were recorded in a group of normally hearing subjects (n = 52 ears) and a group of patients demonstrating several common types of sensorineural hearing loss (n = 85 ears) in order to study the clinical applicability of acoustic emissions. In the normally hearing population, all ears demonstrated acoustic emissions that could be elicited at intensities below the normal subjective threshold for the sequence of clicks (mean, -5.2 dB hearing level [HL]). Sixty-seven percent of the normal ears showed long (greater than 20 ms) click-evoked emissions, and spectral analysis showed a broadband spectral component with several narrowband frequency peaks. In patients with sensorineural hearing loss, the incidence of acoustic emissions decreased and the detection threshold increased linearly with increasing threshold. No emissions were elicited from ears exhibiting subjective click thresholds greater than 35 dB HL. Hearing-impaired ears showed a significantly higher proportion of short duration emissions and a significant reduction in the mean number of narrowband frequency peaks in comparison to the controls. Therefore, acoustic emissions can be used as a reliable technique for objective study of normal micromechanical activity within the cochlea and for detection of subtle changes in cochlear disease. However, they have not been demonstrated to be useful in differentiating cochlear disease.